Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 May 1;90(9):4324–4327. doi: 10.1073/pnas.90.9.4324

Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia.

L Baronciani 1, E Beutler 1
PMCID: PMC46499  PMID: 8483951

Abstract

The intron sequences of the human L-type pyruvate kinase gene (PKLR) were determined by using primers selected from the known cDNA sequence. Oligonucleotide primers for these determined intron sequences were used to sequence the exons. When this technique was applied to the DNA of 10 unrelated patients with pyruvate kinase deficiency, the following eight different mutations in the coding region were detected: del391-393, A401, C464, G721, A1076, T1456, T1484, A1529. The A1529 mutation was found repeatedly in unrelated individuals, even in the homozygous state. The context with respect to a polymorphism at nt 1705 was compatible with a single origin for this mutation, and it may represent a balanced polymorphism. In normal subjects, five differences from the published cDNA sequence were documented.

Full text

PDF
4324

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe S. Secondary red cell pyruvate kinase deficiency. I. Study of 30 subjects of malignant hematological disorders. Nihon Ketsueki Gakkai Zasshi. 1976 Jun;39(3):247–254. [PubMed] [Google Scholar]
  2. Arnold H., Blume K. G., Löhr G. W., Boulard M., Najean Y. "Acquired" red cell enzyme defects in hematological diseases. Clin Chim Acta. 1974 Dec 2;57(2):187–189. doi: 10.1016/0009-8981(74)90429-x. [DOI] [PubMed] [Google Scholar]
  3. Beutler E., Forman L., Rios-Larrain E. Elevated pyruvate kinase activity in patients with hemolytic anemia due to red cell pyruvate kinase "deficiency". Am J Med. 1987 Nov;83(5):899–904. doi: 10.1016/0002-9343(87)90648-6. [DOI] [PubMed] [Google Scholar]
  4. Beutler E., Kuhl W., Gelbart T., Forman L. DNA sequence abnormalities of human glucose-6-phosphate dehydrogenase variants. J Biol Chem. 1991 Mar 5;266(7):4145–4150. [PubMed] [Google Scholar]
  5. Bird A. P. DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res. 1980 Apr 11;8(7):1499–1504. doi: 10.1093/nar/8.7.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kahn A., Marie J., Bernard J. F., Cottreau D., Boivin P. Mechanisms of the acquired erythrocyte enzyme deficiencies in blood diseases. Clin Chim Acta. 1976 Sep 20;71(3):379–387. doi: 10.1016/0009-8981(76)90088-7. [DOI] [PubMed] [Google Scholar]
  7. Kanno H., Fujii H., Hirono A., Miwa S. cDNA cloning of human R-type pyruvate kinase and identification of a single amino acid substitution (Thr384----Met) affecting enzymatic stability in a pyruvate kinase variant (PK Tokyo) associated with hereditary hemolytic anemia. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8218–8221. doi: 10.1073/pnas.88.18.8218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kanno H., Fujii H., Hirono A., Omine M., Miwa S. Identical point mutations of the R-type pyruvate kinase (PK) cDNA found in unrelated PK variants associated with hereditary hemolytic anemia. Blood. 1992 Mar 1;79(5):1347–1350. [PubMed] [Google Scholar]
  9. Nakashima K., Nakashima H., Shimoyama M. Deoxyadenosine triphosphate acting as an energy-transferring molecule in adenosine deaminase inhibited human erythrocytes. Biochim Biophys Acta. 1991 Sep 24;1094(3):257–262. doi: 10.1016/0167-4889(91)90084-b. [DOI] [PubMed] [Google Scholar]
  10. Neubauer B., Lakomek M., Winkler H., Parke M., Hofferbert S., Schröter W. Point mutations in the L-type pyruvate kinase gene of two children with hemolytic anemia caused by pyruvate kinase deficiency. Blood. 1991 May 1;77(9):1871–1875. [PubMed] [Google Scholar]
  11. Noguchi T., Yamada K., Inoue H., Matsuda T., Tanaka T. The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. J Biol Chem. 1987 Oct 15;262(29):14366–14371. [PubMed] [Google Scholar]
  12. Recommended methods for the characterization of red cell pyruvate kinase variants. International Committee for Standardization in Haematology. Br J Haematol. 1979 Oct;43(2):275–286. doi: 10.1111/j.1365-2141.1979.tb03751.x. [DOI] [PubMed] [Google Scholar]
  13. Tani K., Fujii H., Nagata S., Miwa S. Human liver type pyruvate kinase: complete amino acid sequence and the expression in mammalian cells. Proc Natl Acad Sci U S A. 1988 Mar;85(6):1792–1795. doi: 10.1073/pnas.85.6.1792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Valentine W. N., Tanaka K. R., Paglia D. E. Hemolytic anemias and erythrocyte enzymopathies. Ann Intern Med. 1985 Aug;103(2):245–257. doi: 10.7326/0003-4819-103-2-245. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES